Toronto, Canada

Joe McCann

USPTO Granted Patents = 3 

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
3 patents (USPTO):

Title: Joe McCann: Innovator in Radiopharmaceuticals

Introduction

Joe McCann is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative compounds and methods that enhance treatment options in medicine.

Latest Patents

One of Joe McCann's latest patents is related to a radiopharmaceutical known as Lu-PSMA I&T. This compound is provided in high purities with an extended shelf life. The patent also includes methods for synthesizing Lu-PSMA I&T, along with pharmaceutical compositions and treatment methods that incorporate this compound. Another significant patent involves a radiopharmaceutical compound called Lu-DOTATATE. This patent encompasses a composition and a kit, as well as methods for synthesizing Lu-DOTATATE and treatment methods that utilize this compound.

Career Highlights

Throughout his career, Joe McCann has worked with several prominent organizations. He has been associated with Point Biopharma Inc. and the Centre for Probe Development and Commercialization. His experience in these companies has allowed him to contribute to the advancement of radiopharmaceutical technologies.

Collaborations

Joe has collaborated with several professionals in his field, including Justyna Kelly and Paul Billone. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Joe McCann is a distinguished inventor whose work in radiopharmaceuticals has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…